Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel G Wittekind

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 30, 2021
Computational prediction of protein subdomain stability in MYBPC3 enables clinical risk stratification in hypertrophic cardiomyopathy and enhances variant interpretationAndrea D Thompson, Adam S Helms, Anamika Kannan, et al.
European Heart Journal|September 7, 2021
Worldwide differences in primary prevention implantable cardioverter defibrillator utilization and outcomes in hypertrophic cardiomyopathyVictor Nauffal, Peter Marstrand, Larry Han, et al.
Circulation. Genomic and Precision Medicine|August 26, 2020
Spatial and Functional Distribution of <i>MYBPC3</i> Pathogenic Variants and Clinical Outcomes in Patients With Hypertrophic CardiomyopathyAdam S Helms, Andrea D Thompson, Amelia A Glazier, et al.
European Journal of Preventive Cardiology|October 31, 2021
External validation of the HCM Risk-Kids model for predicting sudden cardiac death in childhood hypertrophic cardiomyopathyGabrielle Norrish, Chen Qu, Ella Field, et al.
American Heart Journal|November 14, 2017
Regional variation in quality of life in patients with a Fontan circulation: A multinational perspectiveNicholas D Fogleman, Silke Apers, Philip Moons, et al.
Circulation|May 19, 2020
A Validated Model for Sudden Cardiac Death Risk Prediction in Pediatric Hypertrophic CardiomyopathyAnastasia Miron, Myriam Lafreniere-Roula, Chun-Po Steve Fan, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 30, 2021
Computational prediction of protein subdomain stability in MYBPC3 enables clinical risk stratification in hypertrophic cardiomyopathy and enhances variant interpretationAndrea D Thompson, Adam S Helms, Anamika Kannan, et al.
European Heart Journal|September 7, 2021
Worldwide differences in primary prevention implantable cardioverter defibrillator utilization and outcomes in hypertrophic cardiomyopathyVictor Nauffal, Peter Marstrand, Larry Han, et al.
Circulation. Genomic and Precision Medicine|August 26, 2020
Spatial and Functional Distribution of <i>MYBPC3</i> Pathogenic Variants and Clinical Outcomes in Patients With Hypertrophic CardiomyopathyAdam S Helms, Andrea D Thompson, Amelia A Glazier, et al.
European Journal of Preventive Cardiology|October 31, 2021
External validation of the HCM Risk-Kids model for predicting sudden cardiac death in childhood hypertrophic cardiomyopathyGabrielle Norrish, Chen Qu, Ella Field, et al.
American Heart Journal|November 14, 2017
Regional variation in quality of life in patients with a Fontan circulation: A multinational perspectiveNicholas D Fogleman, Silke Apers, Philip Moons, et al.
Circulation|May 19, 2020
A Validated Model for Sudden Cardiac Death Risk Prediction in Pediatric Hypertrophic CardiomyopathyAnastasia Miron, Myriam Lafreniere-Roula, Chun-Po Steve Fan, et al.
Pageof 4